Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
May 29, 2025

‘First published on Lexology’ By: Sandhya Singh, Sampada Kapoor and Kritika Gandhi Trademarks play a pivotal role in distinguishing the goods or services

Heir of the Family Trademarks
Thought Leadership
May 15, 2025

‘First published on India Business Law Journal’ By: Pravin Anand, Dr. Ajai Garg and Alvin Antony The ascendancy of large language models (LLMs) has

Navigating the AI frontier: India’s sovereign LLM quest
Thought Leadership
Apr 30, 2025

‘First published on Asia IP’ By: Prachi Agarwal and Manan Mondal In a significant ruling, the Division Bench of the Delhi High Court in Wipro Enterprises

Senior user versus junior user: Delhi High Court confirms passing off in a trademark dispute
Thought Leadership
Apr 29, 2025

‘First published on IP Stars’ By: Safir Anand, Omesh Puri and Abhishek Paliwal As the world changes and technology grows fast, the way we think about

The future of trademarks: shaping tomorrow’s brand identity